Comparison of Easy-to-Use Bronchiolitis Scores in the Post-COVID-19 Era-An Observational Study

María Del Mar Martín-Latorre1, Leticia Martínez-Campos1, Manuel Martín-González1,2

  • 1Department of Pediatrics, Torrecárdenas University Hospital, 04009 Almeria, Spain.

PubMed

Insights

The modified Tal score effectively assesses infant bronchiolitis severity post-COVID-19, correlating well with clinical judgment and predicting hospital admission needs. This clinician-friendly tool aids in managing increased bronchiolitis cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Assessment

Background:

  • Infant bronchiolitis incidence has risen significantly in the post-COVID-19 era.
  • Existing severity assessment scores for bronchiolitis often lack clinical user-friendliness.
  • Accurate and simple tools are needed to evaluate disease severity and predict hospitalization.

Purpose of the Study:

  • To identify an easy-to-use clinical score for accurately estimating bronchiolitis severity in infants.
  • To determine which score best predicts the need for hospital admission.
  • To validate the modified Tal score against clinical judgment and other established scales.

Main Methods:

  • An observational, cross-sectional study was conducted in a pediatric hospital from 2021-2022.
  • Five international acute bronchiolitis scales were compared against clinical severity assessments.
  • Three hundred seventy-seven infants diagnosed with acute bronchiolitis participated.

Main Results:

  • The Tal score modified by McCallum demonstrated strong correlation with clinical severity (0.836, p < 0.001).
  • This modified Tal score showed high concordance with Wang (0.820, p < 0.05) and Wood-Downes-Ferrés (0.936, p < 0.001) scores.
  • The modified Tal score's components were significant predictors of hospital admission in multivariate analysis.

Conclusions:

  • The modified Tal score is a clinician-friendly instrument for assessing infant bronchiolitis severity at initial contact.
  • It exhibits excellent agreement with clinical severity evaluations and predicts hospital admission effectively.
  • This score is valuable for managing the increased incidence of bronchiolitis post-COVID-19.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
237
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
238